Pfizer's BRAFTOVI regimen shows improved survival in colorectal cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. IBM
2. PRIM
3. META
4. NAVN
5. CNC
6. KFY
7. ABBV
8. MU
9. DPZ
10. PLTR

Go back to Pfizer's BRAFTOVI regimen shows improved survival in colorectal cancer
Pfizer Inc. (NYSE: PFE) Delayed: 25.08 --0 (-0%)
Previous Close $25.08    52 Week High $37.39 
Open $25.08    52 Week Low $28.25 
Day High $25.08    P/E 15.20 
Day Low $25.08    EPS $1.65 
Volume 161,108